Covered recipient · General Payments record
PAUL D LOBITZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$576.70
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $204.92 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $118.89 | 5 |
| GlaxoSmithKline, LLC. | $45.84 | 2 |
| Abbott Laboratories | $24.85 | 1 |
| ITI, Inc. | $15.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.85 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125029010 | CMS |
| ABBVIE INC. | $16.20 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104893957 | CMS |
| ABBVIE INC. | $33.74 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104893959 | CMS |
| ABBVIE INC. | $20.52 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104893961 | CMS |
| ABBVIE INC. | $31.23 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104893963 | CMS |
| ABBVIE INC. | $17.20 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104893965 | CMS |
| GlaxoSmithKline, LLC. | $24.78 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116694355 | CMS |
| GlaxoSmithKline, LLC. | $21.06 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116253213 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.34 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143266631 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.